SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

FOR IMMEDIATE RELEASE
Washington D.C., Dec. 18, 2020 —
The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.
The SEC's complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics' Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics' stock.

Related Keywords

New York ,United States ,California ,District Of Columbia ,Stephanie Avakian ,Hanel Kim ,James Carlson ,Keith Berman ,Tom Bednar ,Jeff Leasure ,Carlisle Perkins ,Margareta Cain ,David Misler ,Lesley Atkins ,Coronavirus Steering Committee ,Decision Diagnostics Corp ,Financial Industry Regulatory Authority ,Division Of Enforcement ,Us District Court ,Microcap Fraud Task ,Office Of Market Intelligence ,Exchange Commission ,Department Of Justice Market Integrity ,Decision Diagnostics ,Decision Diagnostic ,Associate Director ,Southern District ,Market Integrity ,Major Frauds Unit ,Ernesto Amparo ,Market Intelligence ,Microcap Fraud Task Force ,Financial Industry Regulatory ,புதியது யார்க் ,ஒன்றுபட்டது மாநிலங்களில் ,கலிஃபோர்னியா ,மாவட்டம் ஆஃப் கொலம்பியா ,மாற்றாந்தாய் வாக்கிங் ,ஜேம்ஸ் கார்ல்சன் ,கேய்ட் பெர்மன் ,டோம் பெட்டின் ,ஜெஃப் குத்தகை ,கார்லிஸ்ல் பெர்கின்ஸ் ,லெஸ்லி அட்கின்ஸ் ,முடிவு பரிசோதனை கார்ப் ,நிதி தொழில் ஒழுங்குமுறை அதிகாரம் ,பிரிவு ஆஃப் அமலாக்கம் ,எங்களுக்கு மாவட்டம் நீதிமன்றம் ,அலுவலகம் ஆஃப் சந்தை உளவுத்துறை ,பரிமாற்றம் தரகு ,துறை ஆஃப் நீதி சந்தை நேர்மை ,முடிவு பரிசோதனை ,முடிவு கண்டறியும் ,இணை இயக்குனர் ,தெற்கு மாவட்டம் ,சந்தை நேர்மை ,அர்நெஸ்டோ ஆம்பரோ ,சந்தை உளவுத்துறை ,நிதி தொழில் ஒழுங்குமுறை ,